Heidi Henson

Lisata Therapeutics, Inc.Pardes Biosciences, Inc.Perspective Therapeutics, Inc.

Insider activity · 24 months1 buy0 salesCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 1 buy · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Companies

▲ Purchases (1 ops.)

€95k

▼ Sales (0 ops.)

—

Latest filing published 13 Jan 2026 for LISATA THERAPEUTICS, INC..

Filing timeline

BuySale

Heidi Henson

Insider track record

Disclosed buys

Disclosed sells

Signal history

No signal scores available.

Closed purchases

Market purchases

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Perspective Therapeutics, Inc. 1 purchase · last 06 Dec 2024

Heidi Henson: trading record in brief

Heidi Henson discloses dealings in 3 companies, chiefly Lisata Therapeutics, Inc., Pardes Biosciences, Inc. and Perspective Therapeutics, Inc. The record holds 6 filings, for trades running from 9 January 2023 to 9 January 2026.

No open-market sale appears; the market trades are 1 purchase worth €95k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 4 share grants.

The record was last updated on 13 January 2026 with a share grant in Lisata Therapeutics, Inc. The last insider purchase was made public on 6 December 2024, 687 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.